ecrin-mdr-crcClinical2007Gastrointestinal NeoplasmLung CancerGastrointestinal NeoplasmsSolid TumorSarcomaColorectal CancerHead and Neck CancerBladder CancerPancreatic CancerBreast CancerOvarian CancerProstate CancerDigestive System NeoplasmsCancerGastrointestinal NeoplasmLung CancerSolid TumorGastrointestinal NeoplasmsSarcomaColorectal CancerBladder CancerPancreatic CancerBreast CancerOvarian CancerProstate CancerHead And Neck CancerDigestive System NeoplasmsCancerInterventionalhttps://newmdr.ecrin.org/Study/2039408United States4NeoplasmPicoplatinChemotherapyAdvancedPlatinumTumorECRIN MDRCompletedfalseA Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid TumorsPicoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.2007-04-152039408NCT00465725